Effect of central microinjection of carbenoxolone in an experimental model of focal cerebral ischemia

Pakistan Journal of Pharmaceutical Sciences

Volumn 22, Issue 4, 2009, Pages 349-354

  Khorasani, Mahdi Zahedi ^a   Hosseinzadeh, Seyed Ahmad ^a   Vakili, Abedin ^a  

^a SEMNAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Carbenoxolone; Central injection; Rat; Transient focal cerebral ischemia

Indexed keywords

CARBENOXOLONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; MALE; MICROINJECTION; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR DYSFUNCTION; NONHUMAN; RAT; TREATMENT OUTCOME;

ANIMALS; CARBENOXOLONE; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; DYSKINESIA, DRUG-INDUCED; INFARCTION, MIDDLE CEREBRAL ARTERY; ISCHEMIC ATTACK, TRANSIENT; MALE; MICROINJECTIONS; NEOSTRIATUM; RATS; RATS, WISTAR;

EID: 70349773195     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Brooks PS, Digerness SB, Parks DA and Darley-Usmar V (2002). Mitochondrial function in response to cardiac ischemia-reperfusion after oral treatment with quercetin. Free Radic. Biol. Med., 32: 1220-1228.
2. Azzam EI, de Toledo SM and Little JB (2001). Direct evidence for the participation of gap-junction mediated intercellular communication in the transmission of damage signals from alpha-particle irradiated to nonirradiated cells. Proc. Natl. Acad. Sci. USA., 98: 473-478.
3. Bani-Yaghoub M, Underhill TM and Naus CC (1999). Gap junction blockage interferes with neuronal and astroglial differentiation of mouse P19 embryonal carcinoma cells. Dev. Genet., 24: 69-81. (Pubitemid 29115550)
4. Blanc EM, Bruce-Keller AJ and Mattson MP (1998). Astrocytic gap junctional communication decreases neuronal vulnerability to oxidative stress-induced disruption of calcium homeostasis and cell death. J. Neurochem., 70: 958-970.
5. Bostanci MO and Baǧirici F (2007). Anticonvulsive effects of carbenoxolone on penicillin-induced epileptiform activity: an in vivo study. Neuropharmacology, 52: 362-367.
6. Contreras JE, Sánchez HA, Eugenin EA, Speidel D, Theis M, Willecke K, Bukauskas FF, Bennett MV and Sáez JC (2002). Metabolic inhibition induces opening of unapposed connexin 43 gap junction hemichannels and reduces gap junctional communication in cortical astrocytes in culture. Proc. Natl. Acad. Sci. USA., 99: 495-500.
7. Contreras JE, Sánchez HA, Véliz LP, Bukauskas FF, Bennett MV and Sáez JC (2004). Role of connexinbased gap junction channels and hemichannels in ischemia-induced cell death in nervous tissue. Brain Research Reviews, 47: 290-303.
8. Cotrina ML, Kang J, Lin H-C', Bueno E, HansenTW, He L, Liu Y and Nedergaard M (1998). Astrocytic gap junctions remain open during ischemic conditions. J. Neurosci., 18: 2520-2537. (Pubitemid 28141800)
9. Davidson J.S and Baumgarten I.M (1988). Glycyrrhetinic acid derivatives: a novel class of inhibitors of gapjunctional intercellular communication. J. Pharmacol. Exp. Ther., 246: 1104-1107.
10. De Pina-Benabou MH, Szostak V, Kyrozis A, Rempe D, Uziel D, Urban-Maldonado M, Benabou S, Spray DC, Federoff HJ, Stanton PK and Rozental R (2005). Blockade of gap junctions in vivo provides neuroprotection after perinatal global ischemia. Stroke, 36: 2232-2237. (Pubitemid 41429252)
11. Frantseva MV, Kokarovtseva L and Perez Velazquez JL (2002a). Ischemia induced brain damage depends on specific gap-junctional coupling. J. Cereb. Blood Flow Metab., 22: 453-462. (Pubitemid 34273601)
12. Frantseva MV, Kokarovtseva L, Naus CG, Carlen PL, MacFabe D and Perez Velazquez JL (2002b). Specific gap junctions enhance the neuronal vulnerability to brain traumatic injury. J. Neurosci., 22: 644-653. (Pubitemid 34141745)
13. Goldberg GS, Moreno AP, Bechberger JF, Hearn SS, Shivers RR, MacPhee DJ, Zhang YC and Naus CC (1996). Evidence that disruption of connexon particle arrangements in gap junction plaques is associated with inhibition of gap junctional communication by a glycyrrhetinic acid derivative. Exp. Cell Res., 222: 48-53.
14. Gomez-Sanchez EP and Gomez-Sanchez CE (1992). Central hypertensinogenic effects of glycyrrhizic acid and carbenoxolone. Am. J. Physiol., 263: E1125-1130.
15. Haraguchi H, Ishikawa H, Mizutani K, Tamura Y and Kinoshita T (1998). Antioxidative and superoxide scavenging activities of retrochalcones in Glycyrrhiza inflata. Bioorg. Med. Chem., 6: 339-347. (Pubitemid 28144484)
16. Hayes MJ, Sprackling ML and Angman MJ (1977). Changes in the plasma clearance and protein binding of carbenoxolone with age, and their possible relationship with adverse drug effects. Guthrie Clin. Bull., 18: 1054-1058.
17. Hosseinzadeh H, Nassiri Asl M and Parvardeh S (2005). The effects of carbenoxolone, a semisynthetic derivative of glycyrrhizinic acid, on peripheral and central ischemia-reperfusion injuries in the skeletal muscle and hippocampus of rats. Phytomedicine, 12: 632-637. (Pubitemid 41169809)
18. Hosseinzadeh H and Nassiri AM (2003). Anticonvulsant, sedative and muscle relaxant effects of carbenoxolone in mice. BMC Pharmacol., 29: 1-6. (Pubitemid 38729274)
19. Jellinck PH, Monder C, McEwen BS and Sakai RR (1993). Differential inhibition of 11 beta-hydroxysteroid dehydrogenase by carbenoxolone in rat brain regions and peripheral tissues. J. Steroid Biochem. Mol. Biol., 46: 209-213. (Pubitemid 23251679)
20. Khan AA, Soloski MJ, Sharp AH, Schilling G, Sabatini DM, Li S, Ross CA and Snyder SH (1996). Lymphocyte apoptosis: mediation by increased type 3 inositol 1,4,5-triphosphate receptor. Science, 273: 503-507. (Pubitemid 26286452)
21. Leshchenko Y, Likhodii S, Yue W, Burnham WM and Prez Velazques JL (2006). Carbenoxolone dose not cross the blood brain barrier: an HPLC study. BNC Neurosci., 7: 3-8. (Pubitemid 43193503)
22. Nagy JI and Li WE (2000). A brain slice model for in vitro analyses of astrocytic gap junction and connexin43 regulation: actions of ischemia, glutamate and elevated potassium. Eur. J. Neurosci., 12: 4567-4572.
23. Nyikos L, Lasztóczi B, Antal K, Kovács R and Kardos J (2003). Desynchronisation of spontaneously recurrent experimental seizures proceeds with a single rhythm. Neuroscience, 121: 705-717. (Pubitemid 38367509)
24. Ozog M, Siushansian R and Naus CCG (2002). Blocked gap junctional coupling increases glutamate-induced neurotoxicity in cocultures of neurons and astrocytes. J. Neuropathol. Exp. Neurol., 61: 132-141.
25. th ed.). Orlando, Florida: Academic Press.
26. Perez Velazquez JL, Kokarovtseva L, Sarbaziha R, Jeyapalan Z and Leshchenko Y (2006). Role of gap junctional coupling in astrocytic networks in the determination of global ischaemia-induced oxidative stress and hippocampal damage. Eur. J. Neurosci., 23: 1-10.
27. Saito R, Graf R, Hubel K, Fujita T, Rosner G and Heiss WD (1997). Reduction of infarct Volume by halothane: effect on cerebral blood flow or perifocal spreading depression-like depolarizations. J. Cereb. Blood Flow Metab., 17: 857-864. (Pubitemid 27377640)
28. Salvi M, Fiore C, Battaglia V, Palermo M, Armanini D and Toninello A (2005). Carbenoxolone induces oxidative stress in liver mitochondria, which is responsible for transition pore opening. Endocrinol., 146: 2306-2312. (Pubitemid 40577518)
29. Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C and Sharp FR (1990). Semiautomated method for measuring brain infarct volume. J. Cereb.. Blood Flow Metab., 10: 290-293. (Pubitemid 20096202)
30. Tangri KK, Seth PK, Parmar SS and Bhargava KP (1965). Biochemical study of anti-inflammatory and antiarthritic properties of glycyrrhetic acid. Biochem. Pharmacol., 14, 1277-1281.
31. Turpie AG and Thomson TJ (1965). Carbenoxolone sodium in the treatment of gastric ulcer with special reference to side effects. Gut., 6: 591-594.
32. Ullian ME, Hazen-Martin DJ, Walsh LG, Davda RK and Egan BM (1996). Carbenoxolone damages endothelium and enhances vasoconstrictor action in aortic rings. Hypertension., 27: 1346-1352.
33. Vakili A, Hosseinzadeh F and Toktam Sadogh (2007). Effect of aminoguanidine on post-ischemic brain edema in transient model of focal cerebral ischemia. Brain Res., 1170: 97-102. (Pubitemid 47374656)
34. Vakili A, Kataoka H and Plesnila N (2005). Role of arginine vasopressin V1 and V2 receptors for brain damage after transient focal cerebral ischemia. J. Cerebral Blood Flow Metab., 25: 1012-1019. (Pubitemid 41061716)
35. Vessey JP, Lalonde MR, Mizan HA, Welch NC, Kelly ME and Barnes S (2004). Carbenoxolone inhibition of voltage-gated Ca channels and synaptic transmission in the retina. J. Neurophysiol., 92: 1252-1256.
36. Zhang GY, Cao YH, Xu Y, Wu ZL, Wan Q and Rao ZR (2004). Effect of gap junction in the ischemic injury of focal cerebral infarct. Chinese Journal of Clinical Rehabilitation, 8: 4510-4511. (Pubitemid 39328668)
37. Zhang Y (2002). Determination of furazolidone, carbenoxolone sodium and berberine hydrochloride in wei kang tablets by reversed-phase high performance liquid chromatography (RP-HPLC). Chinese J. Chromatography, 20: 350-352.
38. Zündorf G, Kahlert S and Reiser G (2007). Gap-junction blocker carbenoxolone differentially enhances NMDA-induced cell death in hippocampal neurons and astrocytes in co-culture. J. Neurochem., 102: 508-521. (Pubitemid 47000594)